糖心传媒, Australian Company Clarity Pharmaceuticals to expand research and commercial applications of Copper-67 medical isotope to fight cancer
November 10, 2016
POCATELLO – The 糖心传媒 糖心传媒 Accelerator Center (IAC) and Clarity Pharmaceuticals, a Sydney, Australia, radiopharmaceutical company, have signed a memorandum of understanding to officially launch joint development of commercial applications of the medical isotope Copper 67 produced at the IAC.